Business Description
EGEIRO Pharma
ISIN : BE0974387194
Share Class Description:
XPAR:ALVET: Ordinary SharesCompare
Compare
Traded in other countries / regions
ALVET.France31A.Germany IPO Date
2021-06-17Description
EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.99 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -1.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.9 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | -17.7 | |||||
| 3-Year EPS without NRI Growth Rate | -61.1 | |||||
| 3-Year FCF Growth Rate | -53.2 | |||||
| 3-Year Book Growth Rate | 21.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.89 | |||||
| 9-Day RSI | 52.48 | |||||
| 14-Day RSI | 51.53 | |||||
| 6-1 Month Momentum % | -83.94 | |||||
| 12-1 Month Momentum % | -94.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | |||||
| Quick Ratio | 3.15 | |||||
| Cash Ratio | 2.37 | |||||
| Days Inventory | 47.4 | |||||
| Days Sales Outstanding | 8.79 | |||||
| Days Payable | 52.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.04 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -0.82 | |||||
| Operating Margin % | -219.11 | |||||
| Net Margin % | -176.57 | |||||
| FCF Margin % | -196.04 | |||||
| ROE % | -22.53 | |||||
| ROA % | -18.18 | |||||
| ROIC % | -29.15 | |||||
| ROC (Joel Greenblatt) % | -6560.53 | |||||
| ROCE % | -21.75 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.41 | |||||
| PB Ratio | 0.06 | |||||
| Price-to-Tangible-Book | 0.42 | |||||
| EV-to-EBIT | -7.99 | |||||
| EV-to-EBITDA | -14.65 | |||||
| EV-to-Revenue | 15.47 | |||||
| EV-to-FCF | -7.89 | |||||
| Price-to-Net-Current-Asset-Value | 2.17 | |||||
| Earnings Yield (Greenblatt) % | -12.52 | |||||
| FCF Yield % | -12.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EGEIRO Pharma Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.858 | ||
| EPS (TTM) (€) | -0.469 | ||
| Beta | 0.43 | ||
| Volatility % | 54.44 | ||
| 14-Day RSI | 51.53 | ||
| 14-Day ATR (€) | 0.016185 | ||
| 20-Day SMA (€) | 0.10471 | ||
| 12-1 Month Momentum % | -94.41 | ||
| 52-Week Range (€) | 0.0632 - 1.46 | ||
| Shares Outstanding (Mil) | 122.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EGEIRO Pharma Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EGEIRO Pharma Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
EGEIRO Pharma Frequently Asked Questions
What is EGEIRO Pharma(XPAR:ALVET)'s stock price today?
The current price of XPAR:ALVET is €0.11. The 52 week high of XPAR:ALVET is €1.46 and 52 week low is €0.06.
When is next earnings date of EGEIRO Pharma(XPAR:ALVET)?
The next earnings date of EGEIRO Pharma(XPAR:ALVET) is .
Does EGEIRO Pharma(XPAR:ALVET) pay dividends? If so, how much?
EGEIRO Pharma(XPAR:ALVET) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers